Electron microscopic structure of purified, active gamma-secretase reveals an aqueous intramembrane chamber and two pores by Lazarov, Vlado K. et al.
Electron microscopic structure of purified, active
-secretase reveals an aqueous intramembrane
chamber and two pores
Vlado K. Lazarov*†, Patrick C. Fraering†‡, Wenjuan Ye‡, Michael S. Wolfe‡, Dennis J. Selkoe‡§, and Huilin Li*§
*Biology Department, Brookhaven National Laboratory, Upton, NY 11973; and ‡Center for Neurologic Diseases, Brigham and Women’s Hospital,
Harvard Medical School, Boston, MA 02115
Communicated by Gregory A. Petsko, Brandeis University, Waltham, MA, March 23, 2006 (received for review October 26, 2005)
-Secretase is an intramembrane-cleaving aspartyl protease re-
quired for the normal development of metazoans because it
processes Notch within cellular membranes to release its signaling
domain. More than two dozen additional substrates of diverse
functions have been reported, including the Notch ligands Delta
and Jagged, N- and E-cadherins, and a sodium channel subunit. The
protease is causally implicated in Alzheimer’s disease because it
releases the neurotoxic amyloid -peptide (A) from its precursor,
APP. -Secretase occurs as a large complex containing presenilin
(bearing the active site aspartates), nicastrin, Aph-1, and Pen-2.
Because the complex contains at least 18 transmembrane domains,
crystallographic approaches to its structure are difficult and re-
mote. We recently purified the human complex essentially to
homogeneity from stably expressing mammalian cells. Here, we
use EM and single-particle image analysis on the purified enzyme,
which produces physiological ratios of A40 and A42, to obtain
structural information on an intramembrane protease. The 3D EM
structure revealed a large, cylindrical interior chamber of 20–40
Å in length, consistent with a proteinaceous proteolytic site that is
occluded from the hydrophobic environment of the lipid bilayer.
Lectin tagging of the nicastrin ectodomain enabled proper orien-
tation of the globular,120-Å-long complex within the membrane
and revealed 20-Å pores at the top and bottom that provide
potential exit ports for cleavage products to the extra- and intra-
cellular compartments. Our reconstructed 3D map provides a phys-
ical basis for hydrolysis of transmembrane substrates within a
lipid bilayer and release of the products into distinct subcellular
compartments.
electron microscopy  image analysis  intramembrane protease
Inherited mutations in presenilin (PS), the active site compo-nent of -secretase, which was first recognized as the proteo-
lytic activity responsible for generating amyloid -peptide (A)
via cleavage of APP within cellular membranes, modulate the
intramembrane cleavage of APP to increase levels of the highly
amyloidogenic A42 peptide in humans (1). APP, Notch, and
other -substrates must undergo shedding of their large ectodo-
mains by one of the -secretases or by -secretase before they
can be processed within the membrane by -secretase (2).
Beyond the intense interest in -secretase function for normal
cell biology, the enzyme has emerged as a key therapeutic target
for Alzheimer’s disease, and inhibitor design would be much
facilitated by structural information about the proteolytic mech-
anism. PS is predicted to have eight or nine transmembrane
domains (TMDs) (3–5), and it is catalytically inactive until it
undergoes endoproteolysis between the two TMDs that bear the
aspartates (nos. 6 and 7) to yield a heterodimer of the PS N- and
C-terminal fragments (Fig. 1A). This activation requires the
stepwise assembly of the four-protein complex. The seven-TMD
Aph-1 protein apparently associates with the large, single-pass
nicastrin (NCT) molecule early in the secretory pathway, fol-
lowed by the binding of the uncleaved PS polypeptide and then
the addition of the 2-TMD Pen-2, which allows endoproteolysis
of PS to create the active enzyme (6, 7).
Results
Purified -Secretase Was Active and Produced the Physiological Ratio
of A42A40. To examine the 3D structure of -secretase, we
purified intact, proteolytically active -secretase complexes from
Chinese hamster ovary cells that stably overexpress human PS1,
Aph-1, and Pen-2 in the presence of high levels of endogenous
NCT (designated -30 cells) (8). Western blots of the sample
recovered after the last purification step (Fig. 1C, lane 3) (silver
stains published in ref. 8), combined with in vitro activity assays
performed by using both APP- and Notch-based recombinant
substrates (C100Flag and N100Flag) (Fig. 1D), confirmed that
the purified, four-component -secretase complex was active
and was sensitive to III-31C, (IC50 20 nM), a well characterized
transition-state-analog -secretase inhibitor. Importantly, the
C100Flag cleavage products, A40 and A42, were quantified by
ELISA (Fig. 1E), revealing a physiological A42A40 cleavage
ratio (0.11) indistinguishable from that in normal human cere-
brospinal f luid and plasma (10) and themedia of cultured human
neural cells (11). Moreover, the purified, active complexes
contained no detectable immature NCT (Fig. 1C, top panel,
compare lanes 1 and 3), signifying that the final preparation
contained no significant level of immature complexes. This
conclusion is further supported by nondenaturing blue native
PAGE, which reveals only a single band of 300 kDa that is
immunoreactive for each of the -secretase components (PS1-
NTF, PS1-CTF, Aph-1, NCT, and Pen-2) (see Fig. 4A in ref. 12).
However, we cannot exclude the possibility that a portion of the
purified complexes is proteolytically inactive.
3D Reconstruction of -Secretase Structure from EM Images. EM of
the negatively stained complexes purified from -30 cells in a
final concentration of 0.1% digitonin revealed fields of round,
relatively homogeneous particles that measured 80–100 Å in
diameter (Fig. 1B). This size was consistent with a particle of
300 kDa in mass, a value that has been reported by using
biochemical sizing methods, including blue native PAGE (7, 8,
12). The random conical tilt method (13) was used to generate
a series of initial 3D models, one from each class. The resultant
models were highly similar, as judged by their general appear-
ance and by the cross-correlation coefficients (0.9) (data not
shown). These models were aligned and merged to produce a
starting model (Fig. 2A). A total of 12,000 individual particle
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images were then used for model refinement. The orientations
of the enzyme particles on the supporting carbon film were found
to distribute evenly in angular space (data not shown), likely
because of the round, globular shape of the active protease. The
refined 3D reconstruction is shown in Fig. 2B. A comparison of
eight selected reprojections of the refined 3Dmap (Fig. 2C, rows
1 and 3) with their corresponding class averages (Fig. 2C, rows
2 and 4) revealed essentially the same structural features. The
most striking finding was a large, central low-density region
measuring 40 Å in the longest dimension that was observed in
the center of many of the class averages. The resolution of this
map, as estimated by the Fourier shell correlation of two maps
calculated separately from two halves of the data set, was 15
Å (Fig. 2D) (14, 15).
Lectin Labeling Identified the Location of the NCT Ectodomain. To
determine the basic orientation of the complex in the membrane
and ascertain whether the top surface in our 3D map (as shown
in the first panels of Fig. 2 A and B) faces the extracellular or the
cytoplasmic space, we localized the extracellular domain of the
enzyme complex by taking advantage of the fact that multiple
N-linked oligosaccharide groups occur exclusively in the NCT
ectodomain, and that the plant lectin, Con A, can bind their
mannose and glucose residues highly specifically. Con A is
known to be an asymmetric tetramer (104 kDa) formed by
orthogonal association of two homodimers, with four carbohy-
drate-binding sites exposed at the tip of each monomer (16).
Pure Con A was visible in negatively stained electron micro-
graphs as roughly triangular particles of 30–60 Å in the longest
dimension, depending on their orientation relative to the inci-
dent electron beam (Fig. 3A); this appearance was similar to that
reported for Con A (16). After incubating an aliquot of the
purified -secretase complexes with Con A, we selected 20
-secretase particles with a clearly protuberant Con A attach-
ment for further image analysis (Fig. 3B). Importantly, this
protuberance was never observed in -secretase complexes that
had not undergone Con A labeling. The density attributed to
Con A was then manually masked from the image, and the
resulting raw -secretase particle images were classified with the
reprojections of our 3D reconstruction in a multireference
alignment procedure. This correlative analysis established the
assignment of the extracellular glycosylation sites to the top
density in the 3D reconstruction. Fig. 3B shows the raw images
of four such particles, and Fig. 3C shows the corresponding
reprojections of the model when the Con A structure (Protein
Data Bank ID code 1AZD) was low-pass filtered and manually
placed on the top of the map. We note that the locations of the
Con A in the raw images are generally consistent with those in
the reprojections, but they are not identical, as expected, because
of the multiple Con A binding sites available on the NCT
Fig. 1. Characterization of purified -secretase. (A) Schematic drawing of the predicted transmembrane helices of the four component proteins in -secretase.
(B) Electron micrograph of purified and negatively stained -secretase. (C) Detection by Western blot analysis of all four -secretase components recovered after
the last step of the purification procedure. Twenty-five microliters each of the 1% 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulfonate
(CHAPSO)-solubilized membranes from -30 cells (starting lysate, lane 1), the material not binding to the M2 anti-Flag affinity resin (unbound, lane 2), and the
fraction eluted from the M2 anti-Flag affinity resin (E1, lane 3) were loaded onto a 4–20% Tris-glycine SDSPAGE gel and blotted with R302 (to NCT), Ab14 (to
PS1-holo and -NTF), 13A11 (to PS1-CTF), 3F10 (to Aph-1-HA), and M2 (to Flag-Pen-2). (D) Specific proteolytic activity of the purified -secretase on both APP- and
Notch-based substrates. The eluate fraction (as in C) was incubated in 0.1% phosphatidylcholine, 0.025% phosphatidylethanolamine with a 1 M concentration
of either C100Flag (APP-derived) or N100Flag (Notch-derived) substrates in the absence or presence of a 0.5 M concentration of the active-site-directed
-secretase inhibitor, III-31C, and the respective cleavage products (AICD-Flag and A, or NICD-Flag) were detected as described inMaterials andMethods. Aph-1
serves as an indicator of equal protein loading. (E) Purified -secretase cleavage of C100Flag generates a physiological ratio of A42 and A40 peptides. The
specific eluate (as in C) was diluted in 0.2% CHAPSO-Hepes, pH 7.5, and incubated at 37°C for 4 h with 1 M C100Flag substrate in 0.1% phosphatidylcholine,
0.025% phosphatidylethanolamine, and A40 and A42 were measured by ELISA.
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ectodomain at the top of the -secretase complex (16 potential
sites). Our lectin-binding analysis therefore revealed that the
reconstructed 3D structure of -secretase shown in Fig. 2B (first
panel from the left) is oriented with the top density at the
extracellular surface and the long axis in the membrane bilayer,
so that the smooth and continuous belt-like density (see Fig. 2B
and Fig. 4, described below) faces the hydrophobic lipid envi-
ronment. This orientation is consistent with the knowledge that
all four component proteins (PS1, Aph-1, NCT, and Pen-2) are
integral membrane proteins that can be found together in a
proteolytically active complex on the plasma membrane (17, 18).
Structural Description of the -Secretase Map. The 3D map of the
-secretase complex was rendered into surface views at a
threshold including 80% of the expected molecular mass of the
complex (Fig. 4A and Movie 1, which is published as supporting
information on the PNAS web site). The basic structural features
and the overall size were not sensitive to the particular threshold
used. Purified, active -secretase was an elongated globular
structure, with the longest dimension being 120 Å (in the
membrane) and the other two dimensions perpendicular to the
long axis being 70–80 Å each. A major feature of the 3D map
was a belt-like density 60 Å high circumferentially around the
particle that is very likely to be the transmembrane portion of
-secretase (Fig. 4B). A typical transmembrane helix, such as the
one from rhodopsin structure (Protein Data Bank ID code
1GZM) shown in red, fitted well with the height of the belt-like
density (Fig. 4B). Similar features are often observed in the EM
structures of the membrane-embedded portions of membrane
protein complexes, such as the proton pumping Vo-subcomplex
of the V-ATPase (14) and the voltage-dependent tetrameric K
channel in complex with a Fab fragment (15). A cut-open view
is displayed in Fig. 4C. The most dramatic feature of the
structure was the presence of a low-density central chamber. The
shape of the chamber was irregular, with a diameter of 20–40 Å.
The extracellular density at the top of the map (Fig. 4A, second
row) can be attributed to part of the large (669 aa) ectodomain
of NCT because it comprises a long extracellular polypeptide
(70 kDa) onto which N-linked oligosaccharide groups are
attached. At the display threshold, we observed two openings to
the interior chamber: one of 20 Å size (designated H1) facing
up toward the exterior of the cell and the other 10 Å in size
(designated H2) facing down toward the cytoplasm (Fig. 4A).
We also observed two weak-density regions (asterisks in Fig. 4
A and C) on the attributed intramembrane surface.
Discussion
The most enigmatic feature of -secretase and other intramem-
brane proteases is their location within the hydrophobic envi-
ronment of the membrane and yet their requirement for water
molecules to accomplish peptide bond hydrolysis. How -secre-
tase releases its two cleavage products into distinct subcellular
compartments has also been mysterious. Our 3D EM structure
of the purified, proteolytically active, overexpressed human
enzyme, which contains only mature complexes and produces
physiologically correct ratios of human APP cleavage products,
provides plausible explanations for these questions. The ob-
served interior chamber and apical and basal pores would allow
Fig. 2. 3D reconstruction from particle images of the -secretase complex.
(A) Views of the starting model derived from the random conical tilt method.
In this method, the tilt angle needed for calculating the 3D map is determined
experimentally. (B) Corresponding views of the refined 3D map. (C) A gallery
of selected reprojections of the reconstructed 3D map (rows 1 and 3) and their
corresponding class averages (rows 2 and 4). (D) The Fourier shell correlation
(FSC) curve suggests a resolution of 15 Å.
Fig. 3. Lectin labeling of the -secretase complex. (A) A small area of an
electron micrograph showing the negatively stained Con A particles, which
are known to be 104-kDa asymmetric homotetramers 30–60 Å in size. (B) Four
selected raw particle images of the -secretase–Con A complex. (Scale bar: 100
Å.) (C) The corresponding reprojections of the 3D reconstruction with the
atomic structure of Con A low-pass-filtered and placed at the top when the
map is oriented in the front view (i.e., as in the first panels in Fig. 2 A and B).
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the entry of water molecules and their sequestration from the
lipid surrounded by the proteinaceous microenvironment pro-
vided by the many TMDs. The two thin-density regions in the
transmembrane portion (labeled with asterisks in Fig. 4C) may
represent sites that could be opened up transiently to enable
entrance of the -helically conformed substrates, i.e., the TMDs
of various single transmembrane proteins. After a substrate (e.g.,
C99 of APP or the analogous NE fragment of Notch) enters the
proteinaceous central chamber and undergoes hydrolysis by the
2-aspartate-containing catalytic site in PS, the cleavage product
that includes the extracellular half of the substrate’s TMD (e.g.,
A or Np3) could be released through the H1 channel to the
extracellular surface, and the product that includes the cytoplas-
mic half of the substrate’s TMD plus the intracellular domain
(e.g., AICD or NICD) could be released through the H2 channel
to the cytoplasm (Fig. 4).
If the catalytic site is located inside the proteinaceous chamber
of our 3D structure, the architectural design of -secretase
resembles to some extent that of the well characterized cyto-
plasmic proteasome (19, 20). We note that the -secretase may
employ a compartmentalization strategy similar to that of the
proteasome to prevent uncontrolled proteolysis, given its very
broad substrate specificity (21). Substrate unfolding and gate
opening of the eukaryotic proteasomes are tightly regulated by
ATPases associated with various cellular activities (AAA)-type
proteins (20). In the case of -secretase, there is now strong
evidence that an initial substrate-docking site is near to but
physically distinct from the catalytic site (22). The 3D EM
structure reveals no apparent opening in the transmembrane
portion of the complex through which a docked TMD substrate
could translocate into the central chamber. We postulate that
there may be a gate-opening mechanism at the two low-density
lateral regions of the intramembrane barrel that can transiently
modify the conformation of some of the TMDs. A lateral
gate-opening mechanism was recently proposed for the protein-
conducting channel of Sec61 that enables the translocation of
TMDs into the lipid bilayer (23). In the case of -secretase, a
related mechanism could account for the opposite direction of
TMD translocation: from the lipid bilayer into the central
proteinaceous chamber.
Using the natural affinity of lectins for the glycosylated
ectodomain of NCT allowed its localization within the complex
and revealed that it partially covers the top of the chamber,
limiting the size of the H1 opening to20 Å. This position of the
NCT ectodomain suggests a role as a type of flexible lid that
could regulate the entry of water molecules into the central
chamber and the exit of hydrophilic ectodomain products. This
localization is also quite consistent with the recent discovery that
NCT acts as a type of receptor that binds the extracellular amino
terminus of a substrate to facilitate its subsequent endoprote-
olysis by -secretase within the membrane (24).
Attempts to record cryo-electron microscopic images of
-secretase are underway, but much more purified enzyme will
be needed. However, faithful structures of a large number of
protein complexes have been determined at medium resolution
from images of negatively stained particles such as those we have
analyzed (14, 15, 25–27). This structural analysis of an intramem-
brane-cleaving protease reveals a globular architecture of the
physiologically active -secretase complex, with the long-axis in
the plane of the membrane, a sizable interior chamber, and
discrete openings to the extracellular and cytoplasmic spaces.
We believe that the overall architecture and the interior chamber
of the complex are well determined from the negatively stained
samples, but the precise sizes of the two openings cannot yet be
specified because they could be affected by the local stain salt
affinity and the relatively limited resolution. On the basis of
Fig. 4. 3D structure of the -secretase complex. (A) Surface rendering of the 3D reconstruction. The first row displays side views generated by rotating the map
around a vertical axis, and the second row shows tilted views by rotating around a horizontal axis. The rotation angles are shown within each view. Two openings
at the top and bottom are labeled H1 and H2, respectively, where visible. The top density is labeled NCT because the lectin labeling (Fig. 2) showed that the NCT
ectodomain is located at this surface. (B) The potential transmembrane segment with the belt-like structure is outlined in blue by two parallel dashed lines, 60
Å apart. For size comparison, a typical transmembrane -helix, taken from the rhodopsin structure (Protein Data Bank ID code 1GZM), is shown to the left of
the structure. (C) A cut-open view of the -secretase complex from the side, revealing a large central chamber and one opening (H1) at the top and one at the
bottom (H2). Two weak-density lateral regions are labeled with asterisks.
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these initial views, further structural and biochemical studies
examining expressed, purified -secretase complexes that bear
natural or artificial mutations in the subunit proteins will now
build on this information to steadily refine the EM structure and
reveal details of its unusual mechanism.
Materials and Methods
Purification of -Secretase. The multistep procedure for the high-
grade purification of human -secretase from the -30 cells was
performed as described in ref. 8, except that the III-31C affinity
purification step was omitted.
In Vitro -Secretase Assays. By using the recombinant APP-based
substrate C100Flag and the recombinant Notch-based substrate
N100Flag, -secretase assays were performed as reported in refs. 28
and 29. Briefly, the proteolytic reaction mixtures contained
C100Flag orN100Flag substrate at concentrations of 1M,purified
-secretase solubilized in 0.2% 3-[(3-cholamidopropyl)dimethyl-
ammonio]-2-hydroxy-1-propanesulfonate (CHAPSO)-Hepes (pH
7.5, at 10-fold dilution from stock), 0.025% phosphatidylethano-
lamine (PE), and 0.10% phosphatidylcholine (PC). All reactions
were stopped with 0.5% SDS, and the samples were assayed for
A40 andA42 byELISAas described in ref. 30 or electrophoresed
on 4–20% Tris-glycine gels and transferred to poly(vinylidene
difluoride) membranes to detect AICD-Flag with anti-Flag M2
antibody (1:1,000; Sigma) and NICD with Notch Ab1744 antibody
(1:1,000; Cell Signaling Technology), which is selective for the N
terminus of NICD. Aliquots of the same samples were blotted onto
nitrocellulosemembranes to detectAwith the antibody 6E10. The
-secretase inhibitor III-31C was prepared as described in ref. 28
and added to the reaction mixtures from a DMSO stock (final
DMSO concentration of 1%, which alone did not affect -secretase
activity).
Western Blotting and Antibodies. For Western blot analysis of
PS1-NTF, PS1-CTF, Aph12-HA, Flag-Pen-2, and NCT, the
purified -secretase complexes were run on 4–20% Tris-glycine
PAGE gels, transferred to poly(vinylidene difluoride), and
probed with Ab14 (for PS1-NTF, 1:2,000; gift of S. Gandy,
Jefferson Medical College, Philadelphia), 13A11 (for PS1-CTF,
5 gml; gift of Elan Pharmaceuticals, South San Francisco,
CA), 3F10 (for Aph12-HA, 50 ngml; Roche), anti-Flag M2
(for Flag-Pen-2, 1:1,000; Sigma), or R302 antibodies (for NCT,
1:4,000; gift of D. Miller and P. Savam, Institute for Basic
Research in Developmental Disorders, Staten Island, NY).
Lectin Labeling. The lyophilized Con A was purchased from Sigma.
A stock solution of 5 mgml was prepared in a buffer (10 mM
Hepes, pH 7.0) containing 50 mM NaCl, 1 mM CaSO4, and 1 mM
MnCl2. The mixture of Con A and -secretase at the molar ratio of
3:1 was incubated on ice for 30 min before making EM grids.
EM. The purified -secretase complexes were applied to glow-
discharged carbon-coated copper grids, and excess solution was
blotted before staining with uranyl acetate (2%) for 30 sec. The
stain was blotted, and the grids were left to air dry. Images were
recorded under low dose condition (10 eÅ2) in a JEOL JEM
1200EX electron microscope operated at 120 kV with a mag-
nification of 50,000 and a defocus of 1.5–2.0 m. The best-
stained regions were selected with a charge-coupled device
camera before recording the images on Kodak SO-163 negative
film. Micrographs were inspected with an optical diffraction
apparatus, and only micrographs without drift and astigmatism
were further processed. The micrographs were digitized with a
Nikon Super Coolscan at a step size of 12.7 m, corresponding
to a pixel size of 2.54 Å at the sample level. The size of digitonin
micelles, as observed in EM grids prepared from a digitonin
solution at the same concentration and buffer condition as that
of the purified -secretase preparation, was40–50 Å. Thus, the
detergent micelles were clearly distinguishable from the much
larger -secretase particles.
Image Analysis and 3D Reconstruction. Image analysis was carried
out with SPIDER (31) and EMAN (32). By using SPIDER, the
defocus and amplitude contrast for each EM image were found,
and these parameters were used for correcting the effect of the
contrast transfer function. Raw particle images were subjected to
reference-free classification through multivariate statistic anal-
ysis. For asymmetrical particles, it is essential to establish a
reliable starting model. We used three approaches for this
purpose: a Gaussian ellipsoid with added noise model; a starting
model calculated from selected class averages based on cross-
common line technique; and a model from the random conical
tilt method. These methods resulted in similar but not identical
structures. In the random conical tilt method, the models from
different views were remarkably similar with high correlations,
therefore these models were merged to serve as the starting
model for projection-matching-based refinement. The conver-
gence of the refinement process was monitored by examining the
Fourier shell correlation between the successive 3D reconstruc-
tions. A total of 12,000 particles were used to calculate the final
map. The resolution of the map was estimated by the Fourier
shell correlation of two maps calculated separately from two
halves of the data set. The map was low-pass filtered to the
estimated resolution and rendered into surface views with
CHIMERA (33).
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